Natur Produkt Overview

  • Founded
  • 1993
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4
  • Investments
  • 4

Natur Produkt General Information

Description

Manufacturer and distributor of over-the-counter (OTC) pharmaceuticals. The company develops and markets its pharmaceuticals products under its own trade mark Natur Produkt. The company includes two business units: Natur Produkt International, which produces pharmaceutical products and Natur Produkt Retail, which manages pharmacy chains.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Primary Office
  • Finlandsky Avenue, 4 A
  • Saint Petersburg, 194044
  • Russia
+7 8 (000) 000-00-00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Natur Produkt Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Natur Produkt‘s full profile, request access.

Request a free trial

Natur Produkt Executive Team (2)

Name Title Board Seat Contact Info
Alexey Mehanika General Director
Vladimir Polyakov General Director
To view Natur Produkt’s complete executive team members history, request access »

Natur Produkt Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Natur Produkt‘s full profile, request access.

Request a free trial

Natur Produkt Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 13-Nov-2007 0000000000 Other Healthcare Services
00000 13-Nov-2007 0000000000 Specialty Retail
00000000000 00000 13-Nov-2007 0000000000 Specialty Retail
Allotina (33 Drugstores) 10-Jul-2007 Buyout/LBO Distributors (Healthcare) 000000 00000000
To view Natur Produkt’s complete investments history, request access »